Delivery Order SPE2DB24D9203-SPE2DB24FXBW1

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product, to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, valued at $2,052.68, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,027.10 firm fixed-price delivery order is for the supply of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with an ultimate completion date of October 11, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $7,844.17 firm fixed-price delivery order for the supply of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a performance period ending on December 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,996.50 firm fixed-price delivery order (SPE2DX25F6YXR) is for the provision of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,263.40 firm fixed-price delivery order is for the supply of 4566788078 IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, from common medications to specialized...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,518.88 contract is for the delivery of IOSAT 130 MG TABLET 14S pharmaceutical products to support the medical supply needs of military healthcare facilities. The award is not associated with a specific set-aside designation, allowing DMS Pharmaceutical Group to leverage its small...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) on March 29, 2024. The $13,195.80 firm-fixed-price delivery order is for the supply of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with a performance period running through April 1, 2024. The award was made under DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB, with DLA valued at up to $4,999,999 through the end of 2025. This...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $14,662.00 and an ultimate completion date of March 25, 2024. It is not a set-aside contract. The award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA. This single-award vehicle allows the DLA to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
  • SPE2DB24D9203
    Indefinite Delivery Contract
  • SPE2DB24D9203-SPE2DB24FXBW1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,932.40, is a firm fixed-price delivery order to provide the IOSAT 130 MG TABLET 14S product.

The award is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business likely contributed to securing this direct award. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a wide variety of medications and medical supplies, including both routine and specialized drugs, to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 12/4/24, 10:09 AM